New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
06:46 EDTMNK, CI, QCORPiper does not see heightened risk around Questcor buyout
Piper Jaffray believes Cigna's (CI) coverage policy update regarding Questcor's (QCOR) Acthar Gel is unlikely to have meaningful impact. Piper does not see heightened risk around the closing of Mallinckrodt's (MNK) acquisition of Questcor. Piper says that while Cigna's new language is suggestive of tighter restriction on patient access, there is no "blanket statement that denies coverage beyond the infantile spasms setting." Piper reiterates an Overweight rating on Mallinckrodt with a $90 price target.
News For MNK;QCOR;CI From The Last 14 Days
Check below for free stories on MNK;QCOR;CI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 19, 2014
06:49 EDTCIGovernment says 7.3M in private Obamacare plans, NY Times reports
Subscribe for More Information
September 17, 2014
10:00 EDTCIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
08:38 EDTCICigna upgraded to Positive from Neutral at Susquehanna
As previously reported, Susquehanna upgraded Cigna to Positive from Neutral. The firm believes Cigna's earnings are poised to accelerate driven by a reduction in ACA related losses, conservative medical cost ratio assumptions, buybacks, and normal business growth. Price target raised to $115 from $77.
07:06 EDTCICigna upgraded to Positive from Neutral at Susquehanna
September 16, 2014
07:30 EDTMNKCRT Capital to hold a conference
2nd Annual Investor Conference to be held in Greenwich, CT on September 16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use